William E Fantegrossi Selected Research

nantenine

5/2004

Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William E Fantegrossi Research Topics

Disease

5	Substance-Related Disorders (Drug Abuse) 09/2020 - 10/2011
4	Hypothermia 01/2022 - 09/2013
4	Psychotic Disorders (Schizoaffective Disorder) 02/2018 - 01/2011
4	Hyperthermia 01/2018 - 05/2004
3	Seizures (Absence Seizure) 01/2020 - 01/2011
3	Marijuana Use 02/2018 - 01/2011
2	Opioid-Related Disorders (Opiate Addiction) 01/2019 - 02/2014
2	Catalepsy 01/2016 - 04/2012
1	Tremor (Tremors) 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020
1	Chronic Disease (Chronic Diseases) 01/2019
1	Schizophrenia (Dementia Praecox) 02/2018
1	Chest Pain (Chest Pains) 01/2018
1	Pheochromocytoma 08/2017
1	Tachycardia (Tachyarrhythmias) 11/2014
1	Visceral Pain 11/2014
1	HIV Infections (HIV Infection) 09/2014
1	Pain (Aches) 09/2013
1	Alcoholism (Alcohol Abuse) 06/2013
1	Cocaine-Related Disorders (Cocaine Addiction) 10/2011
1	Mental Disorders (Mental Disorder) 10/2011
1	Panic Disorder (Panic Attack) 01/2011
1	Hallucinations (Hallucination) 01/2011
1	Hypertension (High Blood Pressure) 01/2011
1	Respiratory Insufficiency (Respiratory Failure) 08/2009
1	Hyperalgesia 08/2009
1	Ataxia (Dyssynergia) 12/2005

Drug/Important Bio-Agent (IBA)

11	CannabinoidsIBA 01/2022 - 01/2011
3	Pharmaceutical PreparationsIBA 09/2020 - 09/2013
3	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2020 - 05/2004
3	Opioid Analgesics (Opioids)IBA 01/2019 - 02/2014
3	Serotonin (5 Hydroxytryptamine)IBA 02/2018 - 08/2017
3	SaltsIBA 01/2018 - 09/2014
2	1-pentyl-3-(1-naphthoyl)indoleIBA 01/2022 - 09/2013
2	Synthetic CathinoneIBA 09/2020 - 01/2018
2	Designer DrugsIBA 01/2020 - 01/2016
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2020 - 06/2013
2	LigandsIBA 01/2020 - 06/2013
2	EndocannabinoidsIBA 02/2018 - 06/2013
2	Dopamine (Intropin)FDA LinkGeneric 02/2018 - 01/2018
2	Cocaine (Cocaine HCl)IBA 09/2014 - 10/2011
1	Dronabinol (THC)FDA LinkGeneric 01/2022
1	N- (1- amino- 3- methyl- 1- oxobutan- 2- yl)- 1- (5- fluoropentyl)- 1H- indazole- 3- carboxamideIBA 01/2022
1	5-F-ADB-PINACAIBA 01/2022
1	RimonabantIBA 01/2022
1	VaccinesIBA 09/2020
1	Conjugate VaccinesIBA 09/2020
1	beta-Arrestin 1IBA 01/2019
1	Naltrexone (ReVia)FDA LinkGeneric 01/2019
1	norbuprenorphineIBA 01/2019
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2018
1	Glutamic Acid (Glutamate)FDA Link 02/2018
1	N- (1- amino- 3- methyl- 1- oxobutan- 2- yl)- 1- pentyl- 1H- indazole- 3- carboxamideIBA 01/2018
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2018
1	Glutathione (Reduced Glutathione)IBA 08/2017
1	Clozapine (Clozaril)FDA LinkGeneric 01/2016
1	Phencyclidine (Angel Dust)IBA 01/2016
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2016
1	Serotonin 5-HT2 Receptor AgonistsIBA 01/2016
1	Antipsychotic Agents (Antipsychotics)IBA 01/2016
1	nuciferineIBA 01/2016
1	Morphine (MS Contin)FDA LinkGeneric 11/2014
1	cathinoneIBA 09/2014
1	Methamphetamine (Desoxyn)FDA LinkGeneric 09/2014
1	N- (1- phenethylpiperidin- 4- yl)- N- phenylacetamideIBA 02/2014
1	JWH-073IBA 09/2013
1	Biological ProductsIBA 06/2013
1	sigma Receptors (sigma Receptor)IBA 10/2011
1	Proteins (Proteins, Gene)FDA Link 10/2011
1	Capsaicin (Zostrix)FDA Link 08/2009
1	Alfentanil (Alfenta)FDA LinkGeneric 08/2009
1	Ro 64-6198IBA 08/2009
1	salvinorin AIBA 12/2005
1	volinanserinIBA 05/2004
1	nantenineIBA 05/2004
1	Prazosin (Minipress)FDA LinkGeneric 05/2004

Therapy/Procedure

4	Therapeutics 09/2020 - 06/2013
3	Analgesia 01/2022 - 04/2012
1	Drug Therapy (Chemotherapy) 11/2018
1	Induced Hyperthermia (Thermotherapy) 05/2004